Does Octreotide Acetate Interact with Insulin Human?
Octreotide Acetate and Insulin Human have a major drug interaction according to U.S. FDA drug labeling data. Octreotide inhibits insulin secretion, requiring monitoring and adjustment of anti-diabetic treatment and blood glucose levels. The mechanism involves octreotide inhibits insulin secretion. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Insulin Human Class
- Insulin
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Octreotide Acetate and Insulin Human occurs because octreotide inhibits insulin secretion. Clinically, this means octreotide inhibits insulin secretion, requiring monitoring and adjustment of anti-diabetic treatment and blood glucose levels. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Octreotide Acetate and your doctor is considering prescribing Insulin Human (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider